Status:
UNKNOWN
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18-70 years
Brief Summary
Lung cancer is the leading cause of cancer-related death in Europe. Pathological staging is the gold standard, but it can be influenced by neo-adjuvant treatment and number of sampled lymph nodes; it ...
Detailed Description
Our central hypothesis is that peculiar image-derived and genetic characteristics are consistent with disease stage and patient outcome. Therefore, they are biomarkers of disease burden and relapse, w...
Eligibility Criteria
Inclusion
- Patients with new pathological diagnosis of lung cancer, available baseline imaging (CT and FDG-PET/CT), age \> 18 years, and eligibility for surgery will be considered for inclusion.
Exclusion
- pregnant or breast- feeding women.
Key Trial Info
Start Date :
July 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
415 Patients enrolled
Trial Details
Trial ID
NCT06163846
Start Date
July 10 2020
End Date
June 1 2025
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italy, 20132